Company profile for Neumirna Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NEUmiRNA Therapeutics is a Danish pharmaceutical start-up based in Copenhagen, founded in 2020. The company focuses on achieving transformative disease modification for neurological conditions. Their lead program is an anti-miRNA treatment for patients with epilepsy. The company was co-founded by Dr. Henrik Klitgaard, a renowned figure in epilepsy research and drug development, and Professor Sakari Kauppinen, an expert in RNA/...
NEUmiRNA Therapeutics is a Danish pharmaceutical start-up based in Copenhagen, founded in 2020. The company focuses on achieving transformative disease modification for neurological conditions. Their lead program is an anti-miRNA treatment for patients with epilepsy. The company was co-founded by Dr. Henrik Klitgaard, a renowned figure in epilepsy research and drug development, and Professor Sakari Kauppinen, an expert in RNA/LNA-based therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
A.C. Meyers Vænge 15, Copenhagen
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty